Still long in DNDN.
1. Dendreon was able to bring the loss down to $15M. Duplicate administrative cost will be slashed - no need to have two finance, HR, IT etc depts.
2. The deep pocketed buyer can invest in automation bringing down the manufacturing cost.
3. Avail of the bigger sales force of the buyer which can translate to higher revenue.
4. Potential EU sales.
but you shorted at $24 and was forced to close your position when it went to $50. hehehe
Well, it's either you are right or not. But the reality of it is long loses $2/sh if bk happens while shorts can lose 3 times or more. You can say we are in the same situation but the shorts are in much more worst if they are not right.
Maybe the buyout was expected to close JJ leaves but there still negotiations going on and so the company had to hire a sort of 'interim' CEO to complete the process.
They had a CC last quarter and this quarter is a blowout compared to it.
Dendreon is becoming attractive to be acquired as the revenue went up and loss is way down. Why didn't thy issue a PR about this good earnings report without talking about EU, automation etc. These may be moot now. I feel it will be acquired.
Impressive credential - can we speculate and add J&J to the list of buyer?
W. Thomas Amick
Former Chairman and Chief Executive Officer, Discovery Laboratories Inc.
Age Total Calculated Compensation This person is connected to 43 board members in 7 different organizations across 8 different industries.
See Board Relationships
As of Fiscal Year 2012
Mr. W. Thomas Amick, also known as Tom, served as the Chief Executive Officer of Discovery Laboratories Inc. from October 18, 2010 to January 4, 2013. Mr. Amick served as the Chairman of Aldagen, Inc from March 2005 to February 23, 2010 and its Chief Executive Officer from March 2005 to October 15, 2010 and President until October 15, 2010. He served as Vice President at Johnson & Johnson. During his highly successful 30-year career at the Johnson & Johnson, he was instrumental in establishing the its biotechnology/oncology business. After starting the biotechnology/oncology business within J&J, he advanced to the position of a Vice President of the Oncology Franchise, where he developed one of the most successful businesses in the history of J&J. Mr. Amick also held positions of increasing responsibility including, the President of Janssen Inc. and President of Ortho Biotech Europe, when he oversaw the operation of separate companies in Germany, France, Italy, England, and Canada. He ended his career at Johnson & Johnson as the Vice President of J&J Development Corp. He was Key Advisor at Affinergy, Inc. He was also a Venture Partner at Pappas Ventures. He serves as Chairman of Argolyn Bioscience, Inc. Mr. Amick served as the Chairman of Discovery Laboratories Inc. from March 14, 2007 to January 4, 2013 and as its Director from September 14, 2004 to January 4, 2013. He has been Director of BioRexis Pharmaceuticals Corporation since September 29, 2004. He has been Director of Transport Pharmaceuticals Inc at neXus therapeutics, Inc. since April 26, 2005. He has been Director at Biolex
Sony had bought media entertainment company before - it may add an internet/media company like Yahoo.
Wonder why - usually we're at 200-300K at this time.
With $20B (HBO's pricetag), Yahoo can start one with less cash.
AOL will be a waste of money - they might as well use that money funding exciting start-ups and get shares like with Alibaba. Yahoo should only buy small startup companies that have exciting concepts. I don't think they should even buy Pinterest - expensive to buy and the concept can easily. Yahoo can try replicate them and add more features. Steve Jobs stayed pretty much on the sideline while Blackberry and Nokia fight for the smartphone business. Then he starts to see what he can do to take smartphone to the next level. You do not have to be the first - just need to have the best product out there. I would add that consumers like chich designs. Importantly, you need an excellent Marketing group (innovative young ones) who think what apps, products make the consumers excited.
Maybe Deerfield will be more aggressive.
I can say I use Linkedin 2 to 3 days a month now - used to be daily. Once you have read your colleagues' or friends' credential, there's less interest to actively check the site unless you're looking for work. I see LinkedIn business to decline because it does not have the same appeal as Facebook, Twitter and Pinterest.
since people wants to check restaurant rating and then do their reservation. IMHO, Yelp will rule the restaurant online service.